C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/4985 (2006.01) A61P 1/04 (2006.01) A61P 11/06 (2006.01) A61P 17/04 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2542481
Compounds of the formula (I) and pharmaceutically acceptable salts thereof, wherein Q1 and R1 are defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of various diseases and conditions that respond to treatment by inhibition of tyrosine kinases.
L'invention concerne des composés de formule (I) et leurs sels pharmaceutiquement acceptables, formule dans laquelle Q?1 ¿et? ¿R?1¿ sont définis dans la description. Ces composés et ces sels inhibent l'enzyme IGF-1R et sont utiles pour le traitement et/ou la prévention de différentes maladies et états pathologiques qui réagissent à un traitement par inhibition des tyrosine kinases.
Beck Patricia Anne
Cesario Cara
Cox Matthew
Dong Han-Qing
Foreman Kenneth
Cassan Maclean
Osi Pharmaceuticals Inc.
LandOfFree
Imidazopyrazine tyrosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazopyrazine tyrosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyrazine tyrosine kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1525071